Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Saskatchewan

$29,000.00

ELR-CXC chemokine antagonism in neutrophilic inflammation

EF 2008-09

Résumé
While we understand the basic biology of numerous individual inflammatory molecules in the body, we have yet to generate a reasoned overview of how they interact with each other. Anecdotal evidence suggests that there exists a much greater interdependence of these functions than previously appreciated. We have developed a new anti-inflammatory drug, called G31P, that blocks an entire class of inflammatory molecules, and so is highly effective as an anti-inflammatory drug. In fact, it is much more effective than we would have predicted, so we wish to know exactly how it works in blocking the activities of other classes of inflammatory molecules. We have some evidence that is also blocks processes not traditionally thought of as inflammatory (e.g., the spread of cancer cells through the body). We will use a combination of test tube and live animals studies with lab animals, pre-clinical studies with experimental pigs, and clinical studies with dogs with melanoma tumours to investigate these issues. Overall, these studies are designed allow us to develop G31P for veterinary uses as diverse as pneumonia, arthritis, and cancer.
Programme
Discovery Grants Program - Individual
Emplacement
Saskatchewan, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
227099-2008
Name nom
Gordon, John
Department département
Veterinary Microbiology
Organization id
16
Institution établissement
University of Saskatchewan
Province en
Saskatchewan
Province fr
Saskatchewan
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2008
Award amount
29000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1011
Committee name en
Integrative Animal Biology
Committee name fr
Biologie Animale Intégrative
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5512
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Veterinary sciences
Research subject fr
Médecine vétérinaire
Partie
1
Nb partie
1
Application title
ELR-CXC chemokine antagonism in neutrophilic inflammation
Keyword
NA
Application summary
While we understand the basic biology of numerous individual inflammatory molecules in the body, we have yet to generate a reasoned overview of how they interact with each other. Anecdotal evidence suggests that there exists a much greater interdependence of these functions than previously appreciated. We have developed a new anti-inflammatory drug, called G31P, that blocks an entire class of inflammatory molecules, and so is highly effective as an anti-inflammatory drug. In fact, it is much more effective than we would have predicted, so we wish to know exactly how it works in blocking the activities of other classes of inflammatory molecules. We have some evidence that is also blocks processes not traditionally thought of as inflammatory (e.g., the spread of cancer cells through the body). We will use a combination of test tube and live animals studies with lab animals, pre-clinical studies with experimental pigs, and clinical studies with dogs with melanoma tumours to investigate these issues. Overall, these studies are designed allow us to develop G31P for veterinary uses as diverse as pneumonia, arthritis, and cancer.